© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Checkpoint Therapeutics, Inc. (CKPT) shows an Average True Range (ATR) of 0.03 and an Enterprise Value of 45.45M. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into CKPT's underlying financial health and market activity.
Checkpoint Therapeutics, Inc. (CKPT) technical indicators as of December 22, 2025: the SMA 20 is 2.29%, SMA 50 at 4.14%, and SMA 200 at 28.27%. The RSI 14 value is 80.29, suggesting its current momentum. These technical analysis signals help assess CKPT's price trends and potential future movements.
Checkpoint Therapeutics, Inc. (CKPT) stock performance overview as of December 22, 2025: The 52-week high is $4.28 (currently -5.33% below), and the 52-week low is $2.37 (currently 136.67% above). Over the past year, CKPT's performance is N/A, compared to the S&P 500's 12.87% change.
According to market data, Checkpoint Therapeutics, Inc. (CKPT) stock's recent performance metrics show that over the last month, CKPT is 3.65%, with a Year-to-Date (YTD) performance of 33.12%. Over the past year, the stock has seen a N/A change. These figures summarize CKPT's price movements across various periods, reflecting its historical returns.
According to current financial data, CKPT stock's P/E (TTM) ratio is -0.05, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CKPT, including P/S (8968.86), P/B (0.16), and P/FCF (-10.13), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.